United States Covid-19 Vaccine Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Covid-19 Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Covid-19 Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Covid-19 Vaccine Overall Market Size
2.1 United States Covid-19 Vaccine Market Size: 2021 VS 2027
2.2 United States Covid-19 Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Covid-19 Vaccine Players in United States Market
3.2 Top United States Covid-19 Vaccine Companies Ranked by Revenue
3.3 United States Covid-19 Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Covid-19 Vaccine Companies in United States Market, by Revenue in 2020
3.5 Companies Covid-19 Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Covid-19 Vaccine Players in United States Market
3.6.1 List of Tier 1 Covid-19 Vaccine Companies in United States
3.6.2 List of Tier 2 and Tier 3 Covid-19 Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Covid-19 Vaccine Market Size Markets, 2021 & 2027
4.1.2 DNA
4.1.3 Non-replicating Viral Vector
4.1.4 Protein Subunit
4.1.5 RNA
4.1.6 Others
4.2 By Type - United States Covid-19 Vaccine Revenue & Forecasts
4.2.1 By Type - United States Covid-19 Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Covid-19 Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Covid-19 Vaccine Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Covid-19 Vaccine Market Size, 2021 & 2027
5.1.2 Adults
5.1.3 Children
5.2 By Application - United States Covid-19 Vaccine Revenue & Forecasts
5.2.1 By Application - United States Covid-19 Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Covid-19 Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Covid-19 Vaccine Revenue Market Share, 2016-2027
6 Covid-19 Vaccine Companies Profiles
6.1 Moderna
6.1.1 Moderna Company Details
6.1.2 Moderna Business Overview
6.1.3 Moderna Covid-19 Vaccine Introduction
6.1.4 Moderna Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.1.5 Moderna Recent Developments
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Company Details
6.2.2 CanSino Biologicals Business Overview
6.2.3 CanSino Biologicals Covid-19 Vaccine Introduction
6.2.4 CanSino Biologicals Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.2.5 CanSino Biologicals Recent Developments
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Company Details
6.3.2 Inovio Pharmaceuticals Business Overview
6.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
6.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.3.5 Inovio Pharmaceuticals Recent Developments
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Company Details
6.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction
6.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Company Details
6.5.2 GlaxoSmithKine Business Overview
6.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction
6.5.4 GlaxoSmithKine Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.5.5 GlaxoSmithKine Recent Developments
6.6 Pfizer
6.6.1 Pfizer Company Details
6.6.2 Pfizer Business Overview
6.6.3 Pfizer Covid-19 Vaccine Introduction
6.6.4 Pfizer Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.6.5 Pfizer Recent Developments
6.7 Johnson?Johnson
6.7.1 Johnson?Johnson Company Details
6.7.2 Johnson?Johnson Business Overview
6.7.3 Johnson?Johnson Covid-19 Vaccine Introduction
6.7.4 Johnson?Johnson Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.7.5 Johnson?Johnson Recent Developments
6.8 Heat Biologics
6.8.1 Heat Biologics Company Details
6.8.2 Heat Biologics Business Overview
6.8.3 Heat Biologics Covid-19 Vaccine Introduction
6.8.4 Heat Biologics Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.8.5 Heat Biologics Recent Developments
6.9 Sanofi
6.9.1 Sanofi Company Details
6.9.2 Sanofi Business Overview
6.9.3 Sanofi Covid-19 Vaccine Introduction
6.9.4 Sanofi Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.9.5 Sanofi Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Covid-19 Vaccine Market Opportunities & Trends in United States Market
Table 2. Covid-19 Vaccine Market Drivers in United States Market
Table 3. Covid-19 Vaccine Market Restraints in United States Market
Table 4. Key Players of Covid-19 Vaccine in United States Market
Table 5. Top Covid-19 Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Covid-19 Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Covid-19 Vaccine Revenue Share by Companies, 2016-2021
Table 8. Companies Covid-19 Vaccine Product Type
Table 9. List of Tier 1 Covid-19 Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Covid-19 Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Covid-19 Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Covid-19 Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Covid-19 Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Covid-19 Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Covid-19 Vaccine Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Covid-19 Vaccine Revenue (US$, Mn), 2022-2027
Table 17. Moderna Company Details
Table 18. Moderna Business Overview
Table 19. Moderna Covid-19 Vaccine Product
Table 20. Moderna Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Moderna Recent Developments
Table 22. CanSino Biologicals Company Details
Table 23. CanSino Biologicals Business Overview
Table 24. CanSino Biologicals Covid-19 Vaccine Product
Table 25. CanSino Biologicals Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. CanSino Biologicals Recent Developments
Table 27. Inovio Pharmaceuticals Company Details
Table 28. Inovio Pharmaceuticals Business Overview
Table 29. Inovio Pharmaceuticals Covid-19 Vaccine Product
Table 30. Inovio Pharmaceuticals Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Inovio Pharmaceuticals Recent Developments
Table 32. Shenzhen Geno-Immune Medical Institute Company Details
Table 33. Shenzhen Geno-Immune Medical Institute Business Overview
Table 34. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product
Table 35. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Shenzhen Geno-Immune Medical Institute Recent Developments
Table 37. GlaxoSmithKine Company Details
Table 38. GlaxoSmithKine Business Overview
Table 39. GlaxoSmithKine Covid-19 Vaccine Product
Table 40. GlaxoSmithKine Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. GlaxoSmithKine Recent Developments
Table 42. Pfizer Company Details
Table 43. Pfizer Business Overview
Table 44. Pfizer Covid-19 Vaccine Product
Table 45. Pfizer Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Pfizer Recent Developments
Table 47. Johnson?Johnson Company Details
Table 48. Johnson?Johnson Business Overview
Table 49. Johnson?Johnson Covid-19 Vaccine Product
Table 50. Johnson?Johnson Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Johnson?Johnson Recent Developments
Table 52. Heat Biologics Company Details
Table 53. Heat Biologics Business Overview
Table 54. Heat Biologics Covid-19 Vaccine Product
Table 55. Heat Biologics Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Heat Biologics Recent Developments
Table 57. Sanofi Company Details
Table 58. Sanofi Business Overview
Table 59. Sanofi Covid-19 Vaccine Product
Table 60. Sanofi Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Sanofi Recent Developments
List of FiguresFigure 1. Covid-19 Vaccine Segment by Type
Figure 2. Covid-19 Vaccine Segment by Application
Figure 3. United States Covid-19 Vaccine Market Overview: 2020
Figure 4. United States Covid-19 Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Covid-19 Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2020
Figure 7. By Type - United States Covid-19 Vaccine Revenue Market Share, 2016-2027
Figure 8. By Application - United States Covid-19 Vaccine Revenue Market Share, 2016-2027
Figure 9. Moderna Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. CanSino Biologicals Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Inovio Pharmaceuticals Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. GlaxoSmithKine Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Pfizer Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Johnson?Johnson Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Heat Biologics Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Sanofi Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)